The global wearable biometric monitor market is expected to grow from USD 11.68 billion in 2025 to approximately USD 25.26 billion by 2034, expanding at a robust CAGR of 8.95%. Rising health consciousness, rapid AI integration, and expanded use in chronic disease management are key growth drivers fueling this surge. What Propels the Wearable Biometric […]
Leica Geosystems – Coastal & Shallow Water Mapping via Bathymetric LiDAR Leica Chiroptera 4X The Chiroptera 4X combines bathymetric (green laser) and topographic (near-infrared laser) LiDAR in one seamless system, capturing data both above and below water. It processes full-waveform returns and delivers outstanding point density. It boasts a bathymetric point capture rate of 140,000 points
The Underwater LiDAR market is forecasted to reach a market valuation of USD 1,752.36 million by 2034, up from USD 466.91 million in 2025. This represents a compound annual growth rate (CAGR) of 15.83% over the forecast period from 2025 to 2034. The market’s robust growth is driven by the increasing demand for precise underwater mapping and surveying
Elemental Boron Market Companies American Elements, SB Boron Corporation, 3M, ABSCO Limited, Strem Chemicals, Materion Corporation, Boron Specialties LLC, Höganäs AB, Dandong Chemical Engineering Institute (DCEI), New Metals and Chemicals Ltd., SkySpring Nanomaterials, H.C. Starck Solutions, Advanced Abrasives Corporation, Baoding Zhongpuruituo Technology Co., Ltd., Beijing Xing Rong Yuan Technology Co., Ltd., BASF SE, Thermo Fisher
The global elemental boron market is poised for steady growth, expected to reach a valuation of USD 2.56 billion by 2034, expanding at a CAGR of 2.85% from 2025 to 2034. This growth is underpinned by the increasing adoption of elemental boron in advanced technology sectors such as electronics, aerospace, defense, and renewable energy, coupled with rapid industrialization
The global pharmaceutical spray drying market is set to more than double over the next decade, driven by rapid innovation and demand for advanced drug formulations. The market is projected to reach USD 4.99 billion by 2034, expanding at a robust CAGR of 7.68% from 2025 to 2034—with breakthroughs in AI and continued R&D investment shaping the industry’s future.
Background The rapid electrification of the automotive sector has created a global race to secure sustainable, high-volume battery supply. Stellantis, one of the world’s largest automotive manufacturers (parent company of brands such as Peugeot, Jeep, Fiat, Citroën, and Opel), has partnered with CATL (Contemporary Amperex Technology Co. Limited), the world’s leading EV battery supplier, to
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Companies Vericel Corporation Holostem Terapie Avanzate Anterogen Co. Ltd. BrainStorm Cell Therapeutics Fibrocell Science Cytori Therapeutics TiGenix (Takeda) CORESTEM Inc. Smith & Nephew (via Osiris Therapeutics) Pluristem Therapeutics ThermoGenesis Holdings Regenexx Gilead Sciences Novartis Fate Therapeutics Medeor Therapeutics Lineage Cell Therapeutics GenCure Aastrom Biosciences (Vericel) Celgene
The recent U.S. FDA label updates for CAR T-cell therapies, reducing monitoring burdens, demonstrate regulatory adaptation to improve patient access, potentially expanding treatment reach beyond the current 20% eligible patient coverage. This reflects growing confidence in safety and efficacy, representing a model for other regions to emulate. Key Updates from the FDA 1. Removal of
The autologous stem cell and non-stem cell based therapies market is projected to expand from approximately USD 9.64 billion in 2025 to around USD 25.78 billion by 2034. This growth corresponds to a strong CAGR of 11.55%, showcasing the sector’s rapid evolution driven by technological advancements and rising demand for personalized medicine. The regenerative medicine
